A transgenic mutant with constitutive expression of the ErbB2 in the gallbladder epithelium develops GBC with a 100% penetrance [30] and somatic mutation of Pten leads to biliary hyperplasia and intraheaptic cholangiocarcinoma [31]. The gene discussed is ERBB2; the disease is cholangiocarcinoma.